Phase I Open-Label Trial to Investigate the Pharmacokinetic Interaction Between Rifabutin or Rifampin and a Single Dose of TMC207 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 23 Oct 2017
At a glance
- Drugs Bedaquiline (Primary) ; Rifabutin; Rifampicin
- Indications Mycobacterium avium complex infections; Tuberculosis
- Focus Adverse reactions; Pharmacokinetics
- 23 Oct 2017 Results published in the Antimicrobial Agents and Chemotherapy
- 20 Apr 2017 New safety primary end points has been added to the study.
- 17 Jan 2013 Actual end date (May 2012) added as reported by ClinicalTrials.gov.